Delphia (Usa) Inc. Poseida Therapeutics, Inc. Transaction History

Delphia (Usa) Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$3.08 - $8.73 $54,568 - $154,669	17,717 New	17,717 $54,000
Q2 2022 Aug 15, 2022	SELL	$1.87 - $5.0 $46,626 - $124,670	-24,934 Reduced 61.21%	15,799 $41,000
Q1 2022 May 16, 2022	BUY	$3.22 - $7.04 $131,160 - $286,760	40,733 New	40,733 $182,000

38.5M

377K

22.2K

Ticker PSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,775,600
Market Cap $810M
Description
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...

Get notified when there are updates to the investment portfolio of Delphia (Usa) Inc., based on Form 13F filings with the SEC.

Stay updated on Delphia (Usa) Inc. with notifications on news.